false
0002068385
0002068385
2026-04-26
2026-04-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (date of earliest event reported): April 26, 2026
SHARONAI
HOLDINGS INC.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-43129 |
|
41-2349750 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
745
Fifth Avenue, Suite 500,
New
York, NY 10151
(Address
of principal executive offices, including zip code)
(347)
212-5075
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions (see General Instructions A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class
A Ordinary Common Stock, $0.0001 par value |
|
SHAZ |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01 Entry into a Material Definitive Agreement
Securities
Purchase Agreement
On
April 26, 2026, SharonAI Holdings Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase
Agreement”) with certain qualified institutional buyers relating to the private offering (the “Offering”) of $350 million
aggregate principal amount of the Company’s 6.00% Convertible Senior Notes due 2031 (the “Notes”).
The
Purchase Agreement contains representations and warranties, covenants and other terms customary for an offering of this type. Pursuant
to the Purchase Agreement, from the date of the Purchase Agreement until 30 days after the Effective Date (as defined in the Purchase
Agreement), neither the Company nor any of its subsidiaries may issue, enter into any agreement to issue or announce the issuance or
proposed issuance of any shares of Class A Ordinary Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”)
or Common Stock Equivalents (as defined in the Purchase Agreement), or file any registration statement or any amendment or supplement
thereto, subject to certain exceptions, including, without limitation, the issuance of (i) shares of Common Stock or Common Stock Equivalents
in connection with the sale of CHESS Depository Interests (“CDIs”) and the quotation of the Company’s CDIs on the Australian
Securities Exchange, (ii) the issuance of up to $25,000,000 of shares of Common Stock or Common Stock Equivalents to a strategic transaction
partner with whom the Company has a commercial relationship, or its affiliates, as a subscription or investment and/or (ii) a private
placement, exempt from the registration requirements of the Securities Act of 1933 as amended (the “Securities Act”)
pursuant to Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder, of Common Stock and/or pre-funded Common
Stock warrants with an effective purchase price per share of not less than $55.00. In addition, from the date of the Purchase Agreement
until the one-year anniversary of the Effective Date, the Company is prohibited from effecting or entering into an agreement to effect
any issuance of Common Stock or Common Stock Equivalents involving a Variable Rate Transaction (as defined in the Purchase Agreement),
subject to certain exceptions, including the exceptions referred to above. The net proceeds of the Offering are expected to be
used for GPU and network procurement, along with working capital to support revenue-generating AI cloud deployments.
The
Purchase Agreement is expected to close on or about April 30, 2026, subject to certain customary and other closing conditions, including
the Company’s entry into a binding customer contract for a minimum of 4,068 GPUs in connection with the project called “Sydney
S6 project.”
The
foregoing summary of the Purchase Agreement is qualified in its entirety by reference to the copy of form of Purchase Agreement
attached as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference.
6.00%
Convertible Senior Notes due 2031 and Indenture
The
Company will issue the Notes in the Offering pursuant to the terms and conditions of an Indenture (the “Indenture”) among
the Company, certain of the Company’s material subsidiaries named in the Indenture (the Subsidiary Guarantors”), and U.S.
Bank Trust Company, National Association, as trustee (in such capacity, the “Trustee”). The Indenture will be executed in
connection with the closing of the transactions under the Purchase Agreement.
The
Notes are senior, unsecured obligations of the Company and will mature on May 1, 2031, unless earlier converted or repurchased. Interest
on the Notes will accrue at a rate of 6.00% per year from the first issuance date of the Notes and will be payable quarterly in arrears
on January 1, April 1, July 1, and October 1 of each year, beginning on the first such date that is at least 30 calendar days after the
initial issuance date of the Notes. Holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples
of $1.00 principal amount, for shares of Common Stock, at the option of the holder.
The
Notes initially be represented by one or more registered notes in global form, but may, in certain circumstances, be exchanged for Notes
in definitive form and will be issued in principal amount denominations of $1,000 or any integral multiple of $1,000 in excess thereof,
The
conversion rate for the Notes will initially be 20.7292 shares of Common Stock per $1,000 of the sum of the principal amount of
Notes plus accrued and unpaid interest on such Notes, which is equivalent to a conversion price of approximately $48.24
per share of Common Stock. The initial conversion price of the Notes represents a premium of approximately 20% above the Nasdaq Minimum
Price (as defined in Nasdaq Rule 5635(d)) at the time the Purchase Agreement was executed. The conversion rate for the Notes
is subject to adjustment from time to time in accordance with the terms of the Indenture, including a weighted average adjustment with
respect to dilutive issuances provided that in no event will the Conversion Rate exceed 24.8750 shares of Common Stock per $1,000
of the sum of the principal amount of Notes plus accrued and unpaid interest on such Notes (which is based on the Nasdaq Minimum Price
of $40.201 on the date the Purchase Agreement was executed). In addition, following certain corporate events that occur prior to
the maturity date of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder
who elects to convert its Notes in connection with such a corporate event. The Notes are not redeemable by the Company. The maximum of
8,706,250 shares of the Common Stock may be issued upon conversion of the Notes based on the maximum conversion rate of 24.8750
shares of Common Stock per $1,000 of the sum of the principal amount of Notes plus accrued and unpaid interest on such Notes.
Any
time after the date that is eighteen months after the initial issuance date of the notes and on or before the 20th VWAP Trading
Day immediately preceding the maturity date, the Company has the right to force convert all, or any portion of the Notes, but
only if (i) the Daily VWAP for at least 20 out of 30 consecutive VWAP Trading Days ending on, and including the VWAP Trading Day immediately
before the date the Company gives notice of the forced conversion, exceeds 200% of the Conversion Price (subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
initial issuance date of the Notes); (ii) the daily dollar trading volume (as reported on Bloomberg) of the Common Stock on the Exchange
for at least 20 out of 30 consecutive VWAP Trading Days ending on, and including the VWAP Trading Day immediately before the date
the Company gives notice of the forced conversion is at least $50 million and (iii) the Liquidity Conditions (as defined in the Indenture)
are satisfied. No shares of Common Stock will be issued to a holder in excess of its restricted beneficial ownership percentage, which
is initially 4.99% (and subject to increase on the terms set forth in the Indenture) (the “Restricted Beneficial Ownership
Percentage”). Instead, in lieu of delivery of such shares of Common Stock in excess of the Restricted Ownership Percentage to the
applicable Holder, the Company will issue pre-funded warrants (the “Pre-Funded Warrants”) exercisable for such excess shares
of Common Stock to such Holder. Such Pre-Funded Warrants will be exercisable in perpetuity, issued in book-entry form, have an exercise
price of $0.0001 per share of Common Stock, will have exercise blockers equal to the Restricted Beneficial Ownership Percentage.
If
the Company undergoes a Fundamental Change (as defined in the Indenture), then, subject to certain conditions and except as described
in the Indenture, holders of the Notes may require the Company to repurchase for cash all or any portion of their Notes at a fundamental
change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any,
to, but excluding, the fundamental change repurchase date.
The
Notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Subsidiary Guarantors named in the Indenture, subject
to the terms of the Indenture.
The
Indenture includes customary affirmative and negative covenants, including a debt maintenance covenant and a prohibition on
incurring secured debt in excess of $25 million. The Indenture also sets forth certain events of default after which the Notes may
be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the
Company after which the Notes become automatically due and payable, which include the following:
| ● |
certain
payment defaults on the Notes (which, in the case of a default in the payment of interest on the Notes, will be subject to a 30-day
cure period); |
| |
|
| ● |
failure
by the Company to comply with its obligation to convert the Notes in accordance with the Indenture upon exercise of a holder’s
conversion right; |
| |
|
| ● |
the
Company’s failure to issue the Fundamental Change Repurchase Notice (as defined in the Indenture) within specified periods
of time set forth in the Indenture; |
| |
|
| ● |
the
Company’s failure to comply with certain covenants in the Indenture relating to the Company’s ability to consolidate
with or merge with or into, or sell, lease or otherwise transfer, in one transaction or a series of transactions, all or substantially
all of the assets of the Company and its subsidiaries, taken as a whole, to another person; |
| |
|
| ● |
a
default by the Company in its other obligations or agreements under the Indenture or the Notes if such default is not cured or waived
within 60 days after notice is given in accordance with the Indenture; |
| |
|
| ● |
certain
defaults by the Company or any of its significant subsidiaries with respect to indebtedness for borrowed money of at least $7.5 million; |
| |
|
| ● |
certain
events of bankruptcy, insolvency or reorganization of the Company or any of the Company’s significant subsidiaries and in the
case of any involuntary case or proceeding which remains undismissed and unstayed for a period of 60 consecutive days; |
| |
|
| ● |
a
final judgment or judgments for the payment of $7,500,000 (or its foreign currency equivalent) or more (excluding any amounts covered
by insurance) in the aggregate rendered against the Company or any significant subsidiary, which judgment is not discharged, bonded,
paid, waived or stayed within 60 days after (i) the date on which the right to appeal thereof has expired if no such appeal has commenced,
or (ii) the date on which all rights to appeal have been extinguished; or |
| |
|
| ● |
a
Subsidiary Guarantee with respect to the Notes ceases to be in full force and effect or the Company or any Subsidiary Guarantor denies
or disaffirms its obligations under the Indenture or any Subsidiary Guarantee with respect to the Notes. |
If
certain bankruptcy and insolvency-related events of default occur with respect to the Company, the principal of, and accrued and unpaid
interest, if any, on, all of the Notes then outstanding shall automatically become due and payable. If an event of default with respect
to the Notes, other than certain bankruptcy and insolvency-related events of default with respect to the Company, occurs and is continuing,
the Trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Notes by notice to the Company
and the Trustee, may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the outstanding Notes to be due
and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an
event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the
first 180 days after the occurrence of such an event of default, consist exclusively of the right to receive additional interest on the
Notes.
The
foregoing summary of the Indenture, the Notes and the Subsidiary Guarantees are qualified in their entirety by reference
to the copy of the substantially final form of Indenture attached as Exhibit A to the form of Securities Purchase Agreement,
which it attached as Exhibit 10.1 to this Current Report on Form 8-K, and such Exhibit 10.1 is incorporated herein by reference.
Registration
Rights Agreement
In
connection with the Offering, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”)
on April 26, 2026, pursuant to which the Company agreed to file a registration statement (the “Registration Statement”) with
the Securities and Exchange Commission (the “Commission”) covering the resale of the Notes and the shares of Common Stock
issuable upon conversion of the Notes (collectively, the “Registrable Securities”). Under the Registration Rights Agreement,
the Company is required to file the Registration Statement with the Commission no later than the 45th calendar day following the date
of the Registration Rights Agreement. The Company is required to use its reasonable best efforts to cause the Registration Statement
to be declared effective by the Commission no later than the 60th calendar day following the date of the Registration Rights Agreement
(or the 90th calendar day in the event of a “full review” by the Commission). The Registration Statement is required to be
on Form S-3 (or, if the Company is not then eligible to use Form S-3, on another appropriate form).
If
the Company fails to file the Registration Statement by the required filing date, fails to cause the Registration Statement to be declared
effective by the required effectiveness date, or if the Registration Statement ceases to remain continuously effective as to all Registrable
Securities for more than 20 consecutive calendar days or more than 30 calendar days in any 12-month period (each, an “Event”),
the Company is required to pay to each holder, as partial liquidated damages, an amount in cash equal to 1.0% of the aggregate subscription
amount paid by such holder pursuant to the Purchase Agreement on each monthly anniversary of such Event date until the applicable Event
is cured. The maximum aggregate liquidated damages payable to a Holder under the Registration Rights Agreement is 5.0% of the aggregate
subscription amount paid by such Holder pursuant to the Purchase Agreement. The Registration Rights Agreement also contains customary
indemnification and contribution provisions. In addition, the Company agreed to reimburse Oaktree Fund Administration, LLC for reasonable
and documented legal fees and expenses incurred in connection with the Registration Rights Agreement in an amount not to exceed $50,000.
The
foregoing summary of the Registration Rights Agreement is qualified in its entirety by reference to the copy of the form of Registration
Rights Agreement attached as Exhibit 10.2 to this Current Report on Form 8-K, which is incorporated herein by reference.
Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The
information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item
3.02 Unregistered Sales of Equity Securities.
The
information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
The
Company will issue the Notes in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 promulgated thereunder.
This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities be
offered or sold in the United States absent registration or an applicable exemption from the registration requirements and certificates
evidencing such shares contain a legend stating the same.
The
Notes and the shares of Common Stock issuable upon conversion of the Notes, if any, have not been registered under the Securities Act
and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Item
7.01 Regulation FD Disclosure.
Offering
Press Release
On
April 26, 2026, the Company issued a press release announcing the Offering. A copy of the press release is filed as Exhibit 99.1 to this
Current Report on Form 8-K and incorporated by reference.
Forward-Looking
Statements
Certain
statements in this report, including, the expected closing date, may be considered “forward-looking statements,” such as
statements relating to the Offering. Forward-looking statements include those preceded by, followed by or that include the words “anticipate,”
“expect,” “believe,” “could,” “continue,” “ongoing,” “estimate,”
“intend,” “may,” “plan,” “potential,” “project,” “should,” “target,”
“will,” “would” and similar words. These forward-looking statements speak only as of the date of this report.
Although the Company believes that its assumptions upon which such forward-looking statements are based are reasonable, the Company can
give no assurance that these forward-looking statements will prove to be correct. Forward-looking statements are subject to risks, uncertainties
and other factors that could cause actual results to differ materially from historical experience or from future results expressed or
implied by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to disseminate any updates
or revisions to any forward-looking statements contained herein to reflect any change in the expectations with regard thereto or any
change in events, conditions or circumstances on which any such statement is based, unless required by law.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
Exhibit
Number |
|
Description |
| 10.1* |
|
Form of Securities Purchase Agreement |
| 10.2 |
|
Form of Registration Rights Agreement |
| 99.1 |
|
Press Release, dated April 26, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document). |
*
The schedules (and similar attachments) to this exhibit have been omitted from this filing pursuant to Item 601(b)(10) of Regulation
S-K. The Company agrees to furnish a supplemental copy of any omitted schedule (or similar attachment) to the Securities and
Exchange Commission upon request.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
SHARONAI
HOLDINGS INC. |
| |
|
|
| |
By: |
/s/
James Manning |
| |
Name: |
James
Manning |
| |
Title: |
CEO |
| |
|
|
| Date:
April 28, 2026 |
|
|
Exhibit
99.1

Sharon
AI Enters Into Definitive Agreements for US$350 Million Convertible Note Offering to Expand GPU and Network Procurement
Financing
led by Oaktree Capital with participation from Two Seas Capital and other new and existing institutional investors
New
York, USA, April, 27 2026 – Today, SharonAI Holdings Inc. (NASDAQ:SHAZ) and its subsidiaries (“Sharon AI” or “the
Company”), a leading Australian Neocloud, announced that it has entered into definitive agreements for the purchase of $350 million
of 6% Convertible Senior Notes due in 2031 (the “Notes”). The issue price for the Notes will equal 100% of the principal
amount thereof. The Notes will be sold in a private offering pursuant to Rule 4(a)(2) of the Securities Act of 1933, as amended (the
“Securities Act”) to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the
Securities Act. The offering is expected to close on or about April 30, 2026, subject to certain closing conditions. The financing is
being led by Oaktree Capital Management, L.P. (“Oaktree”), including funds and accounts within Oaktree’s Value Opportunities
investment strategy, with participation from Two Seas Capital LP and other new and existing institutional investors.
The
Notes will be senior obligations of the Company guaranteed by its subsidiaries and will have an initial conversion price of approximately
$48.24, which is an approximately 20% premium to the at-the-market price under Nasdaq Rule 5635(d) on the date of signing, term of 5
years and a coupon of 6% in cash paid quarterly. Each of the Company’s founders have agreed with the purchasers to execute “lock-up”
agreements for periods ending on March 31, 2027, with respect to sales of specified securities, subject to certain exceptions. The proceeds
from the financing will primarily be used to fund GPU and network procurement, along with working capital to support revenue-generating
AI cloud deployments.
Lucid
Capital Markets acted as sole placement agent for this transaction.
Sheppard
Mullin Richter & Hampon served as counsel for Sharon AI for this transaction. Ellenoff Grossman & Schole LLP served as counsel
for the placement agent for this transaction, and Latham & Watkins LLP served as counsel to Oaktree for this transaction.
This
press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale
of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any state or jurisdiction. The Notes have not been registered under the Securities Act, or any applicable
state securities laws, and have been offered only to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities
Act. Unless so registered, the Notes may not be offered or sold in the United States except pursuant to an exemption from the registration
requirements of the Securities Act and any applicable state securities laws.
-ENDS-
Disclosure
Information
Sharon
AI primarily uses its Investor Relations page (https://sharonai.com/investors/) to disclose material non-public information and to comply
with its disclosure obligations under Regulation FD. The Company also notes that, at times, it uses other communication mediums including,
but not limited to, its X account (sharon__ai) and/or LinkedIn account (sharon-AI) to disseminate information about the Company, and
can be additional sources of information outside press releases, regulatory filings with the Securities and Exchange Commission (SEC)
and any other conference calls, webcasts, investor days, etc. that the company may hold.
About
Sharon AI
SharonAI
Holdings Inc. (NASDAQ:SHAZ) and its subsidiaries (“Sharon AI”), a leading Australian Neocloud, is a High-Performance Computing
company focused on Artificial Intelligence and Cloud GPU Compute Infrastructure. Our cloud GPU platform and compute infrastructure is
accelerating the build of AI factories and sovereign AI solutions, powering the next wave of accelerated computing adoption. For more
information, visit www.sharonai.com.
Contacts
Sharon
AI Media Enquiries:
Zachary
Nevas
IMS
Investor Relations
+1
203.972.9200
sharonai@imsinvestorrelations.com
#
# #
Forward-Looking
Statements
This
press release may contain, and our officers and representatives may from time to time make, “forward-looking statements”
within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which are not historical
facts and which are not assurances of future performance. Forward-looking statements are based only on our current beliefs, expectations
and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy
and other future conditions. In some cases you can identify these statements by forward-looking words such as “believe,”
“may,” “will,” “estimate,” “continue,” “anticipate,” “intend,”
“could,” “should,” “would,” “project,” “strategy,” “plan,” “expect,”
“goal,” “seek,” “future,” “likely” or the negative or plural of these words or similar
expressions or references to future periods. Forward-looking statements in this release include specific statements regarding the completion
of the offering and the intended use of proceeds. Examples of such forward-looking statements include but are not limited to express
or implied statements regarding Sharon AI’s management team’s expectations, hopes, beliefs, intentions or strategies regarding
the future including, without limitation, statements regarding:
| ● | Service
and product offerings; |
| ● | Receipt
and use of proceeds; |
| ● | Acceleration
of the deployment of assets; |
| ● | Acceleration
of Sharon AI’s ability to engage with additional potential customers; |
| ● | Expansion
of Sharon AI’s data center footprint; |
| ● | The
firming of Sharon AI’s ability to formally lease additional capacity; and |
| ● | The
strengthening of Sharon AI’s partner network. |
In
addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including
any underlying assumptions, are forward-looking statements. Because forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.
You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially
from those set forth in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.
Important factors that could cause actual results to differ materially from these forward-looking statements include, among others, all
of the risks described in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K filed
with the SEC. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other
filings with the SEC, which are available at www.sec.gov.
The
forward-looking statements and other information contained in this news release are made as of the date hereof and Sharon AI does not
undertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information,
future events or otherwise, unless so required by applicable securities laws.